Literature DB >> 21397687

Identification of Dermcidin as a novel binding protein of Nck1 and characterization of its role in promoting cell migration.

Shun-Li Shen1, Fang-Hua Qiu, Thamara K Dayarathna, Jian Wu, Ming Kuang, Shawn S-C Li, Bao-Gang Peng, Jing Nie.   

Abstract

A distinct feature of hepatocellular carcinoma (HCC) is the tendency of tumor cells to disperse throughout the liver. Nck family adaptor proteins function to couple tyrosine phosphorylation signals to regulate actin cytoskeletal reorganization that leads to cell motility. In order to explore the role of Nck in HCC development, we performed GST pull-down assay using the SH2 domain of Nck1 as bait. The resulting precipitates were separated by 2-DE. Mass spectrometry analysis revealed a group of Nck1 SH2 domain-binding proteins that were differentially expressed in HCC. One of these proteins, dermcidin (DCD), and its interaction with Nck1, was further validated in vitro. GST pull-down assay revealed that Nck1 SH2 domain binds to the phosphotyrosine residue at position 20 (Y20) of the DCD. Pervandate treatment significantly enhanced the interaction between DCD and Nck1. Moreover, we demonstrated that forced expression of DCD could activate Rac1 and Cdc42 and promoted cell migration. Taken together, these data suggest a role of DCD in tumor metastasis. 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21397687     DOI: 10.1016/j.bbadis.2011.03.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  A novel interaction between the SH2 domain of signaling adaptor protein Nck-1 and the upstream regulator of the Rho family GTPase Rac1 engulfment and cell motility 1 (ELMO1) promotes Rac1 activation and cell motility.

Authors:  Guo Zhang; Xia Chen; Fanghua Qiu; Fengxin Zhu; Wenjing Lei; Jing Nie
Journal:  J Biol Chem       Date:  2014-06-13       Impact factor: 5.157

2.  Rac1 protein regulates glycogen phosphorylase activation and controls interleukin (IL)-2-dependent T cell proliferation.

Authors:  Onetsine Arrizabalaga; Hadriano M Lacerda; Ana M Zubiaga; José L Zugaza
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

Review 3.  Preclinical Development of Seriniquinones as Selective Dermcidin Modulators for the Treatment of Melanoma.

Authors:  Amanda S Hirata; James J La Clair; Paula C Jimenez; Leticia Veras Costa-Lotufo; William Fenical
Journal:  Mar Drugs       Date:  2022-04-28       Impact factor: 6.085

4.  NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC.

Authors:  Xia Zhou; Wuan Bao; Danhong Zhang; Yang Yang; Xianghui Du; Guoqin Qiu
Journal:  Cancer Biol Ther       Date:  2021-02-25       Impact factor: 4.742

5.  Descriptive Proteome Analysis to Investigate Context-Dependent Treatment Responses to OXPHOS Inhibition in Colon Carcinoma Cells Grown as Monolayer and Multicellular Tumor Spheroids.

Authors:  Julia Steinmetz; Wojciech Senkowski; Johan Lengqvist; Jenny Rubin; Elena Ossipova; Stephanie Herman; Rolf Larsson; Per-Johan Jakobsson; Mårten Fryknäs; Kim Kultima
Journal:  ACS Omega       Date:  2020-07-06

6.  Characterization of alpha-1-acid glycoprotein as a potential biomarker for breast cancer.

Authors:  Luo Qiong; Jun Yin
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

7.  Dermcidin Enhances the Migration, Invasion, and Metastasis of Hepatocellular Carcinoma Cells In Vitro and In Vivo.

Authors:  Fanghua Qiu; Huajing Long; Lu Zhang; Jieyuan Liu; Zetian Yang; Xianzhang Huang
Journal:  J Clin Transl Hepatol       Date:  2022-01-04

8.  Analysis of Y-P30/Dermcidin expression and properties of the Y-P30 peptide.

Authors:  Marina Mikhaylova; Anne Schumacher; Corinna Borutzki; Janine R Neumann; Tamar Macharadze; Tarek El-Mousleh; Petra Wahle; Ana C Zenclussen; Michael R Kreutz
Journal:  BMC Res Notes       Date:  2014-06-26

9.  Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma.

Authors:  Shun-Jun Fu; Shun-Li Shen; Shao-Qiang Li; Yun-Peng Hua; Wen-Jie Hu; BeiChu Guo; Bao-Gang Peng
Journal:  BMC Cancer       Date:  2018-08-13       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.